Your browser doesn't support javascript.
loading
Antigen Mass May Influence Trastuzumab Concentrations in Cerebrospinal Fluid After Intrathecal Administration.
Le Tilly, Olivier; Azzopardi, Nicolas; Bonneau, Claire; Desvignes, Céline; Oberkampf, Florence; Ezzalfani, Monia; Ternant, David; Turbiez, Isabelle; Gutierrez, Maya; Paintaud, Gilles.
Afiliación
  • Le Tilly O; EA 4245 Transplantation, Immunologie, Inflammation, Université de Tours, Tours, France.
  • Azzopardi N; Department of Medical Pharmacology, CHRU de Tours, Tours, France.
  • Bonneau C; EA 7501 Groupe Innovation et Ciblage Cellulaire, Université de Tours, Tours, France.
  • Desvignes C; Department of Surgery, Institut Curie, Hôpital René Huguenin, Saint Cloud, France.
  • Oberkampf F; EA 4245 Transplantation, Immunologie, Inflammation, Université de Tours, Tours, France.
  • Ezzalfani M; Pilot Centre for Therapeutic Antibodies Monitoring (PiTAM), CHRU de Tours, Tours, France.
  • Ternant D; Department of Oncology, Institut Curie, Hôpital René Huguenin, Saint Cloud, France.
  • Turbiez I; Biometry Unit, Institut Curie, PSL Research University, Paris, France.
  • Gutierrez M; EA 4245 Transplantation, Immunologie, Inflammation, Université de Tours, Tours, France.
  • Paintaud G; Department of Medical Pharmacology, CHRU de Tours, Tours, France.
Clin Pharmacol Ther ; 110(1): 210-219, 2021 07.
Article en En | MEDLINE | ID: mdl-33547646
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Receptor ErbB-2 / Carcinomatosis Meníngea / Trastuzumab / Antineoplásicos Inmunológicos Tipo de estudio: Clinical_trials Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Clin Pharmacol Ther Año: 2021 Tipo del documento: Article País de afiliación: Francia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Receptor ErbB-2 / Carcinomatosis Meníngea / Trastuzumab / Antineoplásicos Inmunológicos Tipo de estudio: Clinical_trials Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Clin Pharmacol Ther Año: 2021 Tipo del documento: Article País de afiliación: Francia